Genuine question (cos I don't want to be accused again of being a shameless pumper ), isn't a pretty common formula for calculating the share price of a company, use of the equation: SP = Net income divided by total number of shares, times a PE Ratio?
So $540 (net) x 287,000 prescriptions (if the US simply matches Japan) = $155m annual net income $155m divided by 1.5B shares = $0.10/share Multiplied by a PE Ratio of 10 = $1.00 per share (I know some have said a PE of 20 or 30 is more usual for biotech, but I'm going conservative).
Am I missing something? If the US sells the same amount of product as Japan, but at the US price of $540 (net), BOT is worth a minimum of $1.00 and that doesn't take into account three times the population, or year-on-year growth, or any of BOT's other products in the pipeline.
Yes?
BOT Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
), isn't a pretty common formula for calculating the share price of a company, use of the equation: SP = Net income divided by total number of shares, times a PE Ratio?
(20min delay)